These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7881702

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Three-month therapy with calcium-heparin in comparison with ticlopidine in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
    Andreozzi GM, Signorelli SS, Cacciaguerra G, Di Pino L, Martini R, Monaco S, Buttò G, Sardina M.
    Angiology; 1993 Apr; 44(4):307-13. PubMed ID: 8457082
    [Abstract] [Full Text] [Related]

  • 3. [Physical training and low-dose heparin-calcium in patients suffering from chronic obliterating arteriopathy of the lower limbs with intermittent claudication].
    Cina G, Vernich M, Campisi C, Cascone C, Ofria F, Leopardi N, Maniscalco G, Moricca N, Ceccarelli V, Paolicelli D, Carbone D.
    Minerva Cardioangiol; 1996 Apr; 44(4):179-85. PubMed ID: 8767599
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of controlled vascular training on the pain free walking distance and plasmaviscosity in patients suffering from peripheral arterial occlusive disease.
    Häfner HM, Jünger I, Geyer A, Jünger M, Strölin A.
    Clin Hemorheol Microcirc; 2009 Apr; 41(1):73-80. PubMed ID: 19136745
    [Abstract] [Full Text] [Related]

  • 6. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
    Claeys LG, Horsch S.
    Int Angiol; 1996 Dec; 15(4):344-9. PubMed ID: 9127776
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Dec; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 11. Endogenous heparin activity is decreased in peripheral arterial occlusive disease.
    Shankar VK, Handa A, Hands L.
    J Vasc Surg; 2008 May; 47(5):1033-8. PubMed ID: 18328667
    [Abstract] [Full Text] [Related]

  • 12. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
    Arosio E, Sardina M, Prior M, De Marchi S, Zannoni M, Bianchini C.
    Eur Rev Med Pharmacol Sci; 1998 May; 2(2):53-9. PubMed ID: 10229559
    [Abstract] [Full Text] [Related]

  • 13. Minimal walking distance following exercise treatment in patients with arterial occlusive disease.
    Rosetzsky A, Struckmann J, Mathiesen FR.
    Ann Chir Gynaecol; 1985 May; 74(6):261-4. PubMed ID: 4096478
    [Abstract] [Full Text] [Related]

  • 14. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.
    Allegra C, Antignani PL, Schachter I, Koverech A, Messano M, Virmani A.
    Ann Vasc Surg; 2008 May; 22(4):552-8. PubMed ID: 18502605
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of the effectiveness of physical training with parenteral drug therapy in Fontaine stage IIb peripheral arterial occlusive disease].
    Streminski JA, de la Haye R, Rettig K, Kuntz G.
    Vasa; 1992 May; 21(4):392-402. PubMed ID: 1485475
    [Abstract] [Full Text] [Related]

  • 16. Randomized trial of the effects of low-dose calcium-heparin in patients with peripheral arterial disease and claudication. Italian CAP Study Group.
    Antonicelli R, Sardina M, Scotti A, Bonizzoni E, Paciaroni E.
    Am J Med; 1999 Sep; 107(3):234-9. PubMed ID: 10492316
    [Abstract] [Full Text] [Related]

  • 17. Treadmill exercise-induced release of endothelin-1 in patients with peripheral arterial occlusive disease at Fontaine stage IIb.
    Mangiafico RA, Malatino LS, Spada RS, Santonocito M, Messina R, Dell'Arte S, Attinà T.
    Int Angiol; 2000 Mar; 19(1):14-7. PubMed ID: 10853680
    [Abstract] [Full Text] [Related]

  • 18. Transcutaneous oxygen tension (TcPO2) in the testing period of spinal cord stimulation (SCS) in critical limb ischemia of the lower extremities.
    Petrakis IE, Sciacca V.
    Int Surg; 1999 Mar; 84(2):122-8. PubMed ID: 10408282
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
    D'Eri A, Martini R, Cordova RM, Trevisan G, Andreozzi GM.
    Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
    Riccioni C, Sarcinella R, Palermo G, Izzo A, Liguori M, Koverech A, Messano M, Virmani A.
    Int Angiol; 2008 Jun; 27(3):253-9. PubMed ID: 18506129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.